Literature DB >> 24676742

Cephazolin and gentamicin are stable in lactate-buffered fresenius peritoneal dialysate for seven days at room temperature.

Gillian K Balbir Singh1, Martin J Wolley, Valmai C Laycock, David M Voss, Martin J Middleditch, Mark R Marshall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676742      PMCID: PMC3968109          DOI: 10.3747/pdi.2013.00013

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  10 in total

1.  Prolonged stability of antimicrobial activity in peritoneal dialysis solutions.

Authors:  David P Dooley; J Robert Tyler; William G Wortham; Linda S Harrison; William F Starnes; George R Collins; Irene S Ozuna; Patty L Violet; John A Ward
Journal:  Perit Dial Int       Date:  2003 Jan-Feb       Impact factor: 1.756

2.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

3.  Stability of cefazolin sodium in four heparinized and non-heparinized dialysate solutions at 38 degrees C.

Authors:  Renee F Robinson; Richard S Morosco; Charles V Smith; John D Mahan
Journal:  Perit Dial Int       Date:  2006 Sep-Oct       Impact factor: 1.756

Review 4.  Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.

Authors:  Filip de Vin; Peter Rutherford; Dirk Faict
Journal:  Perit Dial Int       Date:  2009 Jan-Feb       Impact factor: 1.756

5.  Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients.

Authors:  Joanna R Ghali; Kym M Bannister; Fiona G Brown; Johan B Rosman; Kathryn J Wiggins; David W Johnson; Stephen P McDonald
Journal:  Perit Dial Int       Date:  2011-06-30       Impact factor: 1.756

6.  Stability of cefazolin sodium in peritoneal dialysis solutions.

Authors:  M C Nahata; P A Ahalt
Journal:  Am J Hosp Pharm       Date:  1991-02

7.  Antibiotic stability in commercial peritoneal dialysis solutions: influence of formulation, storage and duration.

Authors:  Darren M Roberts; Geethanie Fernando; Richard F Singer; Karina J Kennedy; Miriam Lawrence; Girish Talaulikar
Journal:  Nephrol Dial Transplant       Date:  2011-02-15       Impact factor: 5.992

8.  In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.

Authors:  D C Halstead; J Guzzo; J A Giardina; A E Geshan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 9.  Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials.

Authors:  Kathryn J Wiggins; David W Johnson; Jonathan C Craig; Giovanni F M Strippoli
Journal:  Am J Kidney Dis       Date:  2007-12       Impact factor: 8.860

10.  Compatibility of cefazolin and gentamicin in peritoneal dialysis solutions.

Authors:  P C Walker; R E Kaufmann; N Massoud
Journal:  Drug Intell Clin Pharm       Date:  1986-09
  10 in total
  1 in total

1.  Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).

Authors:  Dwarakanathan Ranganathan; Saiyuri Naicker; Steven C Wallis; Jeffrey Lipman; Sharad K Ratanjee; Jason A Roberts
Journal:  Perit Dial Int       Date:  2015-10-22       Impact factor: 1.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.